Immune checkpoint inhibitors for first-line treatment of advanced non-small-cell lung cancer: A systematic review and network meta-analysis.

Tzu-Rong PengHung-Hong LinFang-Pei TsaiTa-Wei Wu

Published in: Thoracic cancer (2021)

Pembrolizumab plus platinum-based chemotherapy prevailed in rank in OS, PFS, and ORR benefit. The TRAEs of pembrolizumab plus platinum-based chemotherapy were more than ICI monotherapy and chemotherapy.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
locally advanced
squamous cell carcinoma
rectal cancer
clinical trial
radiation therapy
open label